78 related articles for article (PubMed ID: 1992438)
1. Two c-myb proteins differing by their aminotermini exhibit different transcriptional transactivation activities (yeast/reporter-effector system).
Punyammalee B; Crabeel M; de Lannoy C; Perbal B; Glansdorff N
Oncogene; 1991 Jan; 6(1):11-9. PubMed ID: 1992438
[TBL] [Abstract][Full Text] [Related]
2. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast.
Seneca S; Punyammalee B; Sureau A; Perbal B; Dvorák M; Crabeel M
Oncogene; 1993 Sep; 8(9):2335-42. PubMed ID: 8361752
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation by human c-myb and v-myb genes.
Kalkbrenner F; Guehmann S; Moelling K
Oncogene; 1990 May; 5(5):657-61. PubMed ID: 2189102
[TBL] [Abstract][Full Text] [Related]
4. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
Tantravahi R; Dudek H; Patel G; Reddy EP
Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
6. The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.
Matre V; Høvring PI; Fjeldheim AK; Helgeland L; Orvain C; Andersson KB; Gautvik KM; Gabrielsen OS
Biochem J; 2003 Jun; 372(Pt 3):851-9. PubMed ID: 12628004
[TBL] [Abstract][Full Text] [Related]
7. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
Foos G; Natour S; Klempnauer KH
Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
[TBL] [Abstract][Full Text] [Related]
8. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
9. Regulation of fibroblast growth factor 2 expression in melanoma cells by the c-MYB proto-oncoprotein.
Miglarese MR; Halaban R; Gibson NW
Cell Growth Differ; 1997 Nov; 8(11):1199-210. PubMed ID: 9372243
[TBL] [Abstract][Full Text] [Related]
10. C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences.
Vellard M; Soret J; Viegas-Pequignot E; Galibert F; Nguyen VC; Dutrillaux B; Perbal B
Oncogene; 1991 Apr; 6(4):505-14. PubMed ID: 1840680
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
13. Human c-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter.
Nürnberg W; Artuc M; Nawrath M; Lovric J; Stüting S; Moelling K; Czarnetzki BM; Schadendorf D
Cancer Res; 1995 Oct; 55(19):4432-7. PubMed ID: 7671256
[TBL] [Abstract][Full Text] [Related]
14. An alternatively spliced isoform of B-Myb is a transcriptional inhibitor.
Horstmann S; Ferrari S; Klempnauer KH
Oncogene; 2000 Nov; 19(48):5428-34. PubMed ID: 11114719
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
Dubendorff JW; Lipsick JS
Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
[TBL] [Abstract][Full Text] [Related]
16. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
17. The human A-myb protein is a strong activator of transcription.
Golay J; Loffarelli L; Luppi M; Castellano M; Introna M
Oncogene; 1994 Sep; 9(9):2469-79. PubMed ID: 8058310
[TBL] [Abstract][Full Text] [Related]
18. Activity of a C. elegans GATA transcription factor, ELT-1, expressed in yeast.
Shim YH; Bonner JJ; Blumenthal T
J Mol Biol; 1995 Nov; 253(5):665-76. PubMed ID: 7473742
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of the GATA-1 promoter by a myb-ets-containing mouse retrovirus is mediated by CACCC elements.
Sun-Hoffman L; Aurigemma RE; Sun B; Ruscetti SK
Oncogene; 1996 Sep; 13(5):1037-42. PubMed ID: 8806693
[TBL] [Abstract][Full Text] [Related]
20. Flexibility in the second half-site sequence recognised by the c-Myb R2 domain--in vitro and in vivo analysis.
Ording E; Bergholtz S; Brendeford EM; Jamin N; Gabrielsen OS
Oncogene; 1996 Sep; 13(5):1043-51. PubMed ID: 8806694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
